Sector revisions CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 04:08:29 2026-09-15 EDT			5-day change	1st Jan Change
8.700 ^HKD	-1.86%		-10.12%	+3.20%

07:50am	CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug	MT
06:18am	CSPC Pharmaceutical says SYS6010 granted breakthrough therapy designation by NMPA	RE

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	CSPC PHARMACEUTICAL GROUP LIMITED							23
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	ROCHE HOLDING AG							19
	NOVARTIS AG							22
	ASTRAZENECA PLC							22
	AMGEN INC.							29
	NOVO NORDISK A/S							23
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							27
	BRISTOL-MYERS SQUIBB COMPANY							24
	SANOFI							24
	GSK PLC							21
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	BAYER AG							18
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	HALEON PLC							17
	Average							22
	Weighted average by Cap.							25